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Abstract Human erythrocytes require a continual supply
of glutamate to support glutathione synthesis, but are
unable to transport this amino acid across their cell mem-
brane. Consequently, erythrocytes rely on de novo gluta-
mate biosynthesis from a-ketoglutarate and glutamine to
maintain intracellular levels of glutamate. Erythrocytic
glutamate biosynthesis is catalyzed by three enzymes,
alanine aminotransferase (ALT), aspartate aminotransfer-
ase (AST), and glutamine aminohydrolase (GA). Although
the presence of these enzymes in RBCs has been well
documented, the relative contributions of each pathway
have not been established. Understanding the relative
contributions of each biosynthetic pathway is critical for
designing effective therapies for sickle cell disease,
hemolytic anemia, pulmonary hypertension, and other
glutathione-related disorders. In this study, we use multi-
dimensional
1H–
13C nuclear magnetic resonance (NMR)
spectroscopy and multiple reaction mode mass spectrom-
etry (MRM-MS) to measure the kinetics of de novo glu-
tamate biosynthesis via AST, ALT, and GA in intact cells
and RBC lysates. We show that up to 89% of the eryth-
rocyte glutamate pool can be derived from ALT and that
ALT-derived glutamate is subsequently used for glutathi-
one synthesis.
Keywords Metabolic ﬂux analysis   Glutathione
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Introduction
Glutathione (GSH) plays a central role in repairing oxi-
dative damage to red blood cells (RBCs). Alterations in
glutathione levels have been linked to a variety of human
disorders, including sickle cell disease, hemolytic anemia,
and pulmonary hypertension (Wu et al. 2004). Although all
of the enzymes required for synthesizing glutathione from
its component amino acids (glutamate, cysteine, glycine)
are present in erythrocytes (Majerus et al. 1971; Minnich
et al. 1971), the RBC membrane is essentially impermeable
to glutamate (Sass 1968; Winter and Christensen 1964;
Young et al. 1987). Consequently, RBCs rely on de novo
glutamate biosynthesis to maintain intracellular levels of
this amino acid.
RBCs contain three enzymes for synthesizing glutamate:
alanine aminotransferase (ALT; EC 2.6.1.2), aspartate
aminotransferase (AST; EC 2.6.1.1), and glutamine ami-
nohydrolase (GA; EC 3.5.1.2). ALT and AST synthesize
glutamate from a-ketoglutarate whereas GA synthesizes
glutamate from glutamine (Fig. 1). Since RBC membranes
are permeable to both a-ketoglutarate and glutamine
(Grifﬁth 1981; Sass 1968; Young et al. 1983), all three
mechanisms can potentially inﬂuence intracellular gluta-
mate levels. However, GA is generally thought to be the
main contributor to RBC glutamate biosynthesis (Grifﬁth
1981; Ellory et al. 1983; Niihara et al. 1997; Morris et al.
2008).
We recently reported that roughly one percent of the
glucose consumed by RBCs incubated in an amino acid
free medium is devoted to de novo alanine production
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DOI 10.1007/s10858-011-9481-9(Lewis et al. 2009a, b). Since ALT is the only enzyme for
synthesizing alanine in RBCs, this result suggests that ALT
activity can have a signiﬁcant impact on steady-state glu-
tamate levels. Given that ALT and AST reactions are
readily reversible, and that the substrates for the ALT and
AST reactions are normally present in the serum (Wishart
et al. 2009), we reasoned that aminotransferase reactions
may be playing a signiﬁcant, and currently underappreci-
ated, role in RBC glutamate biosynthesis in vivo.
Although most of the transport and enzymatic kinetics
associated with RBC glutamate metabolism are known
(Grifﬁth 1981), the relative biosynthetic capacities of ALT,
AST, and GA have not been directly evaluated in intact
cells. Understanding the relative contribution of each
pathway is important for designing effective therapies for
diseases related to glutathione deﬁciencies. In this study,
we apply modern metabolomics techniques to measure the
biosynthetic capacities of AST, ALT, and GA in intact
cells and hemolysates. Using multidimensional
1H–
13C
nuclear magnetic resonance (NMR) spectroscopy and
multiple reaction mode mass spectrometry (MRM-MS) we
show that ALT can contribute up to 89% of the intracel-
lular glutamate pool and that ALT-derived glutamate is
incorporated into glutathione. These data argue that ami-
notransferase reactions are more signiﬁcant than GA in
inﬂuencing steady-state levels of glutamate in vivo.
Methods
Preparation of RBCs and lysates
Fresh blood was collected by venipuncture from healthy
human volunteers (n = 3) into heparinized vacutainers.
RBCs were isolated by centrifugation (10 min at 3,0009g),
and the buffy coat was discarded. Samples were washed
three times in isotonic HEPES buffer (25 mM HEPES,
1 mM NaH2PO4, 106 mM NaCl, 19 mM KCl, 1 mM
CaCl2, pH 7.4), combined into a single pool, and resus-
pended at 20% hematocrit in HEPES buffer containing
20 IU/mL Penicillin/Streptomycin (Gibco). Lysates were
prepared from washed RBCs suspended at 36% hematocrit.
RBCs were hemolyzed by sonication for 1 min and the
resulting lysates were diluted to the equivalent of 25%
hematocrit with isotonic HEPES buffer containing metab-
olite standards (see aminotransferase activity assays in
RBC lysates). All sample preparations were conducted at
4C to minimize metabolic activity.
Metabolic activity assays in intact RBCs
Washed RBCs were prepared in isotonic HEPES buffer
containing either (i) 5 mM [U–
13C]-glucose (Isotec), (ii)
5 mM glucose, 5 mM alanine, and 5 mM [
13C1,2,3,4]-a-
ketoglutarate (Cambridge Isotope Laboratories) or (iii) 5
mM glucose and 1 mM [U
13C–
15N] glutamine. Each RBC
suspension was split into three replicate samples, which
were incubated at 37C over periods of (i, iii) 12 h or (ii)
21 h. Aliquots (1 mL) were collected from samples after
incubation times of 0, 1.5, 3, 6, 12, and 21 h (only ii) and
ﬂash frozen in liquid nitrogen. Metabolites were then
extracted from each sample (as described below) and
analyzed by NMR spectroscopy and MS for the presence of
isotopically enriched molecules. Enriched metabolites were
identiﬁed and quantiﬁed by NMR, and the isotopic
enrichments were determined by MS. Samples containing
[U–
13C]-glucose (i) provided information about glycolyti-
cally-related metabolism; samples containing [
13C1,2,3,4]-a-
ketoglutarate (ii) provided information on aminotransferase
reactions; and samples containing [U
13C–
15N] glutamine
(iii) provided information on glutamine aminohydrolase
activity.
Aminotransferase activity assays in RBC lysates
RBC lysates were incubated at 37C for 6–12 h in isotonic
HEPES buffer containing 200 lM pyridoxal-50-phosphate
(PLP; the cofactor required by aminotransferases) and one
of the following pairs of substrates (5 mM each): pyru-
vate ? glutamate for alanine aminotransferase (ALT)
assays, alanine ? a-ketoglutarate for reverse ALT assays,
oxaloacetate ? glutamate for aspartate aminotransferase
(AST) assays, aspartate ? a-ketoglutarate for reverse AST
assays, and pyruvate plus one of each of the amino acids
listed in Fig. 3 for aminotransferase screening assays.
Aliquots (900 lL) of each sample were collected after 0, 1,
3, 6 and 12 h of incubation and ﬂash frozen in liquid
nitrogen. Metabolites were then extracted (as described
below) and analyzed by NMR.
Fig. 1 Reaction mechanisms for (I) alanine aminotransferase (ALT)
and (II) aspartate aminotransferase (AST). Unlike glutamate, both
alanine and a-ketoglutarate cross the RBC membrane; ALT and AST
provide a mechanism for de novo glutamate production that could
support glutathione biosynthesis
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Samples were placed in a boiling water bath for 7.5 min to
lyse cells and halt enzymatic activity. Boiled lysates were
spun at 16,0009g to pellet cellular debris. For samples to
be analyzed by LC–MS/MRM, a 200 lL aliquot of each
supernatant was transferred to a fresh tube and stored at
-80C until analysis. For samples to be analyzed by NMR,
an 800 lL aliquot of each supernatant was dried in a
SpeedVac Concentrator (Thermo Scientiﬁc), and the
resulting residue was dissolved in 800 lLD 2O containing
500 lM NaN3 and 500 lM 4,4-dimethyl-4-silapentane-1-
sulfonic acid (DSS).
NMR spectroscopy
NMR data were collected at the National Magnetic Reso-
nance Facility at Madison. Two-dimensional sensitivity
enhanced
1H–
13C HSQC spectra were collected on a Var-
ian 600 MHz spectrometer equipped with a cryogenic
probe. Spectra were collected, following 16 transients to
achieve steady state, as four averaged transients with 128
increments in the second dimension (50 increments for the
in vivo labeling studies). The acquisition time was 300 ms
(3,000 data points), following an initial delay of 1 s; the
carbon spectral width was 70 ppm. Time-domain data were
Fourier transformed with a shifted exponential sine-bell
window function, phased, and chemical shift referenced to
DSS using custom nmrDraw (Delaglio et al. 1995) scripts
written in-house.
Our methods for identifying and quantifying metabolites
by
1H–
13C NMR have been described elsewhere (Lewis
et al. 2009a, b; Lewis et al. 2007). Brieﬂy, metabolites
were identiﬁed using the Madison Metabolomics Consor-
tium Database (MMCD) (Cui et al. 2008); assignments
were veriﬁed by overlaying NMR spectra of standards from
the BioMagResBank (BMRB) (Markley et al. 2007);
metabolite concentrations were calculated from peak
intensities on the basis of calibration curves from metab-
olite standards prepared at 2, 5, and 10 mM. The rNMR
software package (Lewis et al. 2009a, b) was used in
performing all NMR data analyses.
Mass spectrometry
Mass spectra were collected at the University of Wisconsin
Biotechnology Center Mass Spectrometry Facility. An
aliquot (5 lL) of each metabolite extract was analyzed by
liquid chromatography (LC) MS on an Applied Biosystems
3200 Q TRAP LC–MS/MS system equipped with an
Agilent 1100 series capillary LC pump and an elec-
trospray ionization (ESI) source. Online LC used a
4.69 150 mm Phenomenex Luna hydrophylic interaction
chromatography (HILIC) column (200-A ˚ pore size, 5-lm
particle size) with a constant ﬂow rate of 200 lL/min.
Samples were eluted over a 48-min ammonium formate
(50 mM, pH 5.4; buffer A) to acetonitrile gradient. The
elution gradient was constructed as follows: 90% A at time
zero, 70% A at 20 min, holding at 70% A for 2 min, 10%
A at 22 min, holding at 10% A for 1 min, back to 90% A at
23 min, and isocratic at 90% A until 48 min. ESI–MS was
performed in positive ion multiple reaction mode (MRM).
Peak picking and integration were accomplished with
Analyst software (Applied Biosystems). Metabolite iden-
tiﬁcation, retention times, and ion fragment patterns,
were veriﬁed by reference to standard compounds. The
Kombyonyx isotope calculator (www.kombyonyx.com)
was used to calculate isotopomer distributions.
Regression analyses and statistics
Rates of metabolite consumption and production were
calculated by linear regression of metabolite concentration
as a function of time. Regression analyses were based on
all time points, except for samples incubated with aspar-
tate ? a-ketoglutarate and oxaloacetate ? glutamate.
Kinetics observed in the latter samples were nonlinear
because of spontaneous decarboxylation of oxaloacetate to
pyruvate (Hatch and Heldt 1985). For these samples, initial
rates were determined from the time points between 0 and
1 h. Samples incubated with [
13C1,2,3,4] a-ketoglutarate
contained contaminating [
13C1,2,3,4] glutamate, which was
determined from the 0 h time points and used as a baseline
for subsequent measurements. Glutamate kinetics from
cells incubated with [
13C1,2,3,4] a-ketoglutarate were
derived from linear regression of the ﬁrst three time points.
All of the p values presented here were derived from a two-
tailed equal variance t-test.
Results
Reports of de novo alanine synthesis by intact RBCs
(Lewis et al. 2009a, b; Manuel y Keenoy et al. 1991)
suggest an active role for aminotransferases in maintaining
intracellular glutamate levels. We conﬁrmed these reports
by incubating RBCs in 5 mM [U–
13C] glucose and mea-
suring the appearance of
13C enriched alanine by
1H–
13C
NMR (Fig. 2). The rate of
13C alanine production we
observed (0.022 ± 0.001 lmol mL
-1 RBC h
-1) is con-
sistent with our previous ﬁndings and accounted for 1.1%
of the total
13C output (Table 1). LC–ESI–MS analyses
indicated that 35% of the total alanine pool was uniformly
13C labeled after 12 h of incubation with [U–
13C] glucose,
whereas samples harvested at 0 h showed natural abun-
dance
13C levels (Table 2).
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To screen for alanine synthesis reactions, we incubated
RBC lysates for 6 h in HEPES buffered saline containing
5 mM pyruvate, 200 lM pyridoxal-50-phosphate (PLP),
and 5 mM target amino acid.
1H–
13C NMR analysis of the
lysates showed signiﬁcant alanine and a-ketoglutarate
production in the sample incubated with glutamate as the
target amino acid (Fig. 3).
Conversion of glutamate ? pyruvate to a-ketoglutar-
ate ? alanine in the presence of PLP is consistent with the
established alanine aminotransferase (ALT) reaction
mechanism (Fig. 1) and is indicative of aminotransferase
activity in the lysates. However, ALT is present in serum,
and contaminating enzyme from the wash medium could
inﬂuence our results. To control for contaminating ALT,
both serum and the ﬁnal RBC wash buffer were assayed for
ALT activity using the method we applied to the RBC
lysates. Although ALT activity was observed in serum
samples (2.82 ± 0.32 lmol alanine produced over 12 h),
the ﬁnal RBC wash buffer showed no detectable ALT
activity (Fig. 4). These ﬁndings demonstrate that our assay
is sufﬁciently sensitive to detect serum levels of ALT and
that the ALT activity observed in RBC lysates did not
result from extracellular ALT.
Glutamate biosynthesis via aminotransferase reactions
can be limited by either transport or reaction kinetics. To
determine the maximum enzymatic rates of the AST and
ALT reactions under physiologically-relevant conditions
with naturally-occurring levels of enzymes, we incubated
RBC lysates for 12 h with 200 lM PLP and saturating
levels of substrates for the two aminotransferases (Fig. 1).
We determined both the forward and reverse reaction rates
for each aminotransferase.
1H–
13C NMR analysis of the
lysates showed efﬁcient conversion of a-ketoglutarate to
glutamate in the presence of either aspartate or alanine
(5.32 ± 0.45 and 0.42 ± 0.03 lmol mL
-1 lysate h
-1,
respectively), indicating that RBCs have a high enzymatic
capacity for both AST and ALT reactions. Similarly, glu-
tamate was efﬁciently converted to a-ketoglutarate in the
presence of either pyruvate or oxaloacetate (Fig. 5). As
expected, rate constants observed for the forward and
reverse reactions were comparable (Table 3).
Interpretation of the AST reaction is complicated by the
rapid spontaneous degradation of oxaloacetate to pyruvate
(Hatch and Heldt 1985). RBC lysates incubated with
Fig. 2 Glucose, lactate, alanine, and pyruvate metabolism observed
in human RBCs. Samples were incubated with 5 mM [U–
13C]
glucose and metabolites were quantiﬁed by
1H–
13C NMR. Error bars
represent S.E.M. (n = 3)
Table 1 Rates of glucose, lactate, alanine, pyruvate and glutamate metabolism observed in intact RBCs
Metabolite(s) added Observed rates of biosynthesis from the labeled substrate (lmol mL
-1 RBC h
-1)
a
Glucose Lactate Alanine Pyruvate Glutamate a-Ketoglutarate
[U–
13C6] glucose -0.78 ± 0.03 1.89 ± 0.01 0.02 ± 0.001 0.01 ± 0.002 n.o.
b n.o.
b
[
13C1,2,3,4] a-ketoglutarate, glucose, alanine -0.80 ± 0.01
c 1.35 ± 0.02
c -0.11 ± 0.07
c 0.57 ± 0.04
c 0.17 ± 0.01
c -0.16 ± 0.06
c
[U
13C-
15N] glutamine, glucose -0.91 ± 0.03 2.13 ± 0.04 n.o.
b n.o.
b 0.004 ± 0.001 n.o.
b
a Means and S.E.M. for n = 3
b n.o. = not observed
c 21 h time point was excluded in the rate calculation
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duction comparable to samples incubated with pyru-
vate ? glutamate (Table 3). This non-intuitive result is
caused by a three-part coupled reaction involving conver-
sion of aspartate to oxaloacetate via AST, spontaneous
degradation of oxaloacetate to pyruvate (Hatch and Heldt
1985), and the subsequent conversion of pyruvate to ala-
nine via ALT.
Glutamate and glutathione synthesis in intact RBCs
GA is generally considered to be the main glutamate bio-
synthesis pathway in RBCs (Grifﬁth 1981; Ellory et al.
1983; Niihara et al. 1997; Morris et al. 2008), but the high
levels of ALT and AST activity we observed in RBC
lysates suggest that aminotransferases can have a signiﬁ-
cant impact on steady-state glutamate levels. However, the
Table 2 Isotopomer distribution of alanine in RBCs incubated with [U–
13C] glucose
Time (h) Percent mass isotopomer distribution (alanine)
a
Monoisotopic M ? 1M ? 2M ? 3M ? 4
0 95.6 ± 0.4 2.43 ± 0.63 n.d.
b 1.94 ± 0.51 0
12 60.6 ± 1.1** 4.04 ± 0.04* n.d.
b 35.4 ± 1.1** 0
Expected distribution due to natural abundance 95.92 3.62 0.44 0.01 0
a Means and S.E.M. for n = 3
b n.d. = not determined
* p\0.05; ** p\0.001
Fig. 3 Aminotransferase screening assay used to determine the
alanine biosynthetic route in human RBCs. Cell lysates were
incubated with 200 lM pyridoxal-50-phosphate, 5 mM pyruvate,
and 5 mM of a target amino acid. Each square shows the unique
1H–
13C NMR sub-spectrum used to identify and quantify each
metabolite observed in the RBC lysates. Row labels denote the
compounds added to samples, and column labels denote metabolite
signals observed by
1H–
13C NMR. In the ﬁrst row, no amino acid was
added in addition to pyruvate; in subsequent rows, the indicated
amino acid was added in addition to pyruvate. Abbreviations: Pyr
pyruvate, aKG a-ketoglutarate, amino acids are represented by
standard three letter code.
The samples prepared with glutamate
showed signals from both the substrate (glutamate) and the two
products (alanine and a-ketoglutarate).
Samples incubated with
glutamine showed no detectable levels of GA activity. However, GA
activity was detectable by MS
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123extent to which aminotransferases contribute to glutamate
biosynthesis in intact cells is limited by the transport rates
for the various substrates. Aspartate transport previously
has been shown to be low (5 lMh
-1) (Fincham et al.
1987; Maede et al. 1983), and thus is a limiting factor in
AST-derived glutamate production. However, the sub-
strates of the GA and ALT reactions previously were
shown to be efﬁciently transported at similar rates (108 and
256 lMh
-1, for glutamine and alanine respectively)
(Niihara et al. 1997), which argues that both GA and ALT
reactions contribute to the glutamate pool. To determine
the relative contributions of ALT and GA to the total
glutamate pool of intact cells, we incubated RBCs with
13C
labeled precursors of the ALT and GA reactions and
measured the appearance of
13C in glutamate and gluta-
thione by
1H–
13C NMR and LC–MS/MRM.
Rates of ALT-derived glutamate were derived from
RBCs incubated for 21 h with glucose, alanine, and
[
13C1,2,3,4] a-ketoglutarate (5 mM each). Intact RBCs pro-
duced
13C-enriched glutamate at an average rate of
0.17 lmol mL
-1 RBC h
-1 and consumed alanine at a rate
of 0.11 lmol mL
-1 RBC h
-1 (Table 1). MS analysis
showed that 89% (p\0.001 relative to natural abundance)
of the RBC glutamate pool was [
13C1,2,3,4] labeled after
21 h (Table 4), indicating active de novo glutamate syn-
thesis by intact cells. Although ALT-derived glutathione
biosynthetic rates were below the NMR detection limit, MS
analysis showed signiﬁcant (p\0.05 relative to natural
abundance)
13C1,2,3,4 isotopic enrichment in the glutamate
Fig. 4 Metabolic activity of ﬁnal wash buffer used for RBC
preparation.
1H–
13C NMR signals indicating no detectable amino-
transferase activity after 12 h of incubation. Abbreviations: aKG a-
ketoglutarate, Pyr pyruvate; amino acids are represented by their
three letter codes
Fig. 5 Aminotransferase
reactions catalyzed by (a,
b) alanine aminotransferase and
(c, d) aspartate aminotransferase
observed in human RBC lysates.
Samples were incubated with
5 mM of each substrate and
analyzed by
1H–
13C NMR. The
title of each plot indicates which
substrates were added. Error
bars represent S.E.M. (n = 3)
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dependent enrichment of glutathione over the course of the
experiment (Table 5). Rates of GA-derived glutamate
production were derived from RBCs incubated in glucose
(5 mM) and [U
13C-
15N] glutamine (1 mM). GA-derived
glutamate was produced at a rate 30 times lower
(0.0039 ± 0.00065 lmol mL
-1 RBC h
-1) than rates
observed for ALT-derived glutamate (Table 1).
Discussion
Human erythrocytes require a continual supply of gluta-
mate to support glutathione synthesis, but are unable to
transport this amino acid across their cell membrane (Sass
1968; Winter and Christensen 1964; Young et al. 1987).
Although glutamine aminohydrolase is often cited as the
main contributor to intracellular glutamate levels (Ellory
Table 3 Rates of ALT and AST aminotransferase reactions observed in RBC lysates
Metabolites added Observed rates (lmol mL
-1 lysate h
-1)
a
Alanine a-Ketoglutarate Aspartate Glutamate Pyruvate
alanine ? a-ketoglutarate
d -0.78 ± 0.11 -0.77 ± 0.08 n.o.
b 0.42 ± 0.03 0.46 ± 0.03
glutamate ? pyruvate
d 0.94 ± 0.03 0.57 ± 0.01 n.o.
b -0.76 ± 0.04 -0.46 ± 0.06
aspartate ? a-ketoglutarate
e 0.49 ± 0.17 -3.23 ± 0.75
c -5.85 ± 0.30
c 5.32 ± 0.45
c 0.73 ± 0.05
glutamate ? oxaloacetate
e -0.73 ± 0.05 2.13 ± 0.54
c 1.98 ± 0.53
c -1.87 ± 0.28
c -0.18 ± 0.04
a Means and S.E.M. for n = 3
b n.o. = not observed
c Rate was calculated using the ﬁrst two time points
d ALT pathway
e AST pathway
Table 4 Isotopomer distribution of glutamate in RBCs incubated with [
13C1,2,3,4] a-ketoglutarate, alanine, and glucose
Time (h) Percent Mass isotopomer distribution (glutamate)
a
Monoisotopic M ? 1M ? 2M ? 3M ? 4
0 95.3 ± 1.7 4.66 ± 1.66 0 0 0
6 15.9 ± 0.7** 0.72 ± 0.08** 0.10 ± 0.10 2.52 ± 0.37* 80.8 ± 0.3**
12 10.4 ± 0.7** 0.41 ± 0.01** 0 3.08 ± 0.55* 86.1 ± 0.9**
21.25 7.47 ± 0.24** 0.24 ± 0.01** 0 2.82 ± 0.14* 89.4 ± 0.3**
Expected distribution due to natural abundance 93.40 5.64 0.91 0.05 0.00
a Means and S.E.M. for n = 3
* p\0.05; ** p\0.001
Table 5 Isotopomer distribution of GSH in RBCs incubated with [
13C1,2,3,4] a-ketoglutarate, alanine, and glucose
Time (h) Percent Mass isotopomer distribution (GSH)
a
Monoisotopic M ? 1M ? 2M ? 3M ? 4
0 85.6 ± 2.5 11.4 ± 2.9 1.47 ± 0.86* 1.59 ± 0.81 0
6 86.6 ± 1.1 7.99 ± 0.19* 1.67 ± 0.45* 0.33 ± 0.33 3.42 ± 0.33**
12 80.9 ± 0.8 8.08 ± 0.60 2.11 ± 0.34* 0.80 ± 0.42 8.09 ± 0.15**
21.25 78.4 ± 0.9* 7.96 ± 0.67 1.03 ± 0.52* 1.38 ± 0.18* 11.3 ± 1.2*
Expected distribution due to natural abundance 82.93 10.90 5.43 0.62 0.10
a Means and S.E.M. for n = 3
* p\0.05; ** p\0.001
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123et al. 1983; Grifﬁth 1981; Morris et al. 2008; Niihara et al.
1997), rates of glutathione biosynthesis are considerably
higher than the maximum capacity of GA to produce glu-
tamate. Even by conservative estimates (Grifﬁth 1981),
demand from glutathione biosynthesis is nearly 8 times
higher than the rates of GA-derived glutamate production
observed in this study (Fig. 6). The discrepancy between
glutamate demand and GA’s biosynthetic capacity argues
that GA is a minor contributor to the glutamate pool.
In contrast to our GA ﬁndings, we found that up to 89%
of the intracellular glutamate pool of intact cells can be
attributed to alanine aminotransferase. ALT activity
observed in this study exceeded GA activity by 30 fold and
was considerably greater than demand from glutathione
synthesis. As expected, ALT-derived glutamate is ulti-
mately incorporated into glutathione. These ﬁndings
clearly demonstrate that ALT can be a major contributor to
steady-state glutamate levels of intact RBCs and argue that
in vivo glutamate synthesis is predominantly attributable to
ALT.
The biological signiﬁcance of the high aspartate ami-
notransferase activity we observed in this study is unclear.
Although RBC membranes are essentially impermeable to
aspartate (Fincham et al. 1987; Maede et al. 1983), the
intracellular machinery for converting aspartate to gluta-
mate is nearly 13 times more efﬁcient than ALT. Since
mature erythrocytes lack the enzymes required for
oxaloacetate synthesis, the presence of AST cannot be
attributed to aspartate biosynthesis. One possible explana-
tion for the presence of AST is that the enzyme is a
developmental holdover from reticulocytes, which syn-
thesize oxaloacetate as a part of the tricarboxylic acid cycle
(Gasko and Danon 1972).
In summary, we evaluated three possible pathways for
glutamate production in RBCs using
1H–
13C NMR and MS
metabolomics techniques. Of these pathways, only ALT
provides a plausible mechanism for supporting glutathione
synthesis in intact cells. Given that human RBCs are
readily permeable to cysteine and glycine (Harvey and
Ellory 1989), and that all of the glutathione biosynthetic
steps are well characterized (Majerus et al. 1971; Minnich
et al. 1971), the ALT mechanism presented here provides a
simple explanation for the sole unresolved step in gluta-
thione biosynthesis.
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